课题基金 / 基金详情

Simultaneous Imaging and Drug Delivery for Prostate Cancer Theranostics

Simultaneous Imaging and Drug Delivery for Prostate Cancer Theranostics
前列腺癌治疗诊断的同步成像和药物输送
批准号:
nhmrc : 1046831
负责人:
A/Pr Kristofer Thurecht
金额:
$37.69万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2016-12-31

项目摘要

项目成果

A/Pr Kristofer Thurecht的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prostate cancer (PC) is the most common cancer in men over 50. The answers to the key questions in advanced PC (Who to treat, and how to treat: loco-regionally or systemically?) rest with clinical staging – something that has hitherto been very imprecise. We have generated a highly-sensitive 19F-molecular imaging agent which could help resolve both questions and create a targeted therapy, diminishing the burden of harm of today’s therapies by using nanoparticles to diagnose and treat PC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Next generation imaging to bridge the knowledge gap in nanomedicine delivery
  • 批准号:
    nhmrc : 1148582
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $32.23万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Kristofer Thurecht
  • 依托单位:
Next generation imaging to bridge the knowledge gap in nanomedicine delivery
  • 批准号:
    nhmrc : GNT1148582
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $47.67万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Kristofer Thurecht
  • 依托单位:
Immuno-polymeric drugs for prostate cancer therapy
  • 批准号:
    nhmrc : GNT1099321
  • 项目类别:
    Project Grants
  • 资助金额:
    $62.7万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Kristofer Thurecht
  • 依托单位:
Immuno-polymeric drugs for prostate cancer therapy
  • 批准号:
    nhmrc : 1099321
  • 项目类别:
    Project Grants
  • 资助金额:
    $43.0万
  • 财政年份:
    2016
  • 负责人:
    A/Pr Kristofer Thurecht
  • 依托单位:
国内基金
海外基金
非小细胞肺癌Biomarker的Imaging MS研究新方法
  • 批准号:
    30672394
  • 项目类别:
    面上项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2006
  • 负责人:
    陆豪杰
  • 依托单位: